Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
NCT ID: NCT02216877 Phase: PHASE1 Status: COMPLETED Enrollment: 36 Completion: 2015-04
Conditions
Chronic Kidney Disease, Hypomagnesemia
Interventions
Mablet 360 mg, Placebo
Summary
Randomized placebo-controlled interventional trial to investigate the effect of oral magnesium supplementation on intracellular magnesium in subjects with chronic kidney disease. We hypothesize that oral magnesium supplementation will increase intracellular magnesium in subjects with chronic kidney disease as well as increase serum magnesium.
Primary Outcome
Intracellular magnesium